Jump to page content

The goal of the International Health-Tech Pilot Program at the Israel Innovation Authority (IIA) is to give substance to the MoU by establishing transnational joint projects. This includes co-development and optimization of new technologies and medical innovations by Israeli start-ups together with researchers at Charité and BIH to ultimately enhance patient care in Germany and beyond. Israel has been called ‘start-up nation’ for their high potential of innovation and the largest number of start-ups per capita worldwide. Only in cooperation with a researcher at Charité and/or BIH, Israeli start-ups can apply for the program and will have the opportunity to receive funding by the IIA (up to 50% of the project’s R&D budget) as well as access to resources and clinical expertise at Charité and BIH.

Other partners within the International Health-Tech Pilot Program are  (in alphabetic order) Hartford HealthCare (HCC), Connecticut, USA, Mayo Clinic, Minnesota, USA and Thomas Jefferson University, Pennsylvania, USA. They provide highest quality for Israeli companies to pilot, test, adapt or optimize innovative medical technologies, services and products.

1 - How to participate

This program is directed to clinician researchers at Charité / BIH who are interested in a cooperation project with an Israeli start-up company or who are already working with an Israeli start-up company. This does not include binational cooperation between laboratories/work groups.

Eligible start-up companies for cooperation projects will be published in July 2020.

If you have any questions concerning the program, please refer to Maria Rönnefarth (Coordination of the project, Clinical Trial Unit – Clinical Study Center (CSC), BIH, Charité) or Luise Tavera (Speaker Strategic Cooperation in BIH-Innovation, Tech Transfer, BIH)

2 - Application process and Selection procedure

Every researcher or clinician at the BIH and Charité can apply for joining the program, including principal investigators, postdoctoral researchers, and graduate students. However, each application must be signed or co-signed by a principal investigator (Arbeitsgruppenleiter*in) who needs to be an employee of BIH, Charité or MDC. The Clinical Study Center (CSC) is looking for researchers interested in cooperation and willing to receive further information or getting to know Israeli start-ups. Please find the list of the Israeli Start-Ups available for joint projects on this website beginning of July. Furthermore, an already established cooperation can gather more information on funding process through the IIA program.

The CSC can help to establish contact with Israeli companies, provide information about the project and support proposal preparation. The Israeli start-up has applied for funding at the Israeli Innovation Authority. Successful applicant companies from Israel will receive funding directly from the Israel Innovation Authority.

3 - Formal criteria

The applicant must be a medical doctor or a comparable scientific degree. Co-funding of the same project by third parties is not permitted. Teams can apply as well. At least one applicant must be an employee of Charité or Max Delbrück Center.

Here you can find further information on the International Health-Tech Pilot Program.

Project head

Dr. med. Sein Schmidt
Scientific and Medical Director, Clinical Trial Unit – Clinical Study Center (CSC), BIH, Charité


Contact persons

  • Dr. med. Sein Schmidt

    Scientific and Medical Director of the Clinical Trial Unit of the Clinical Study Center (CSC), BIH, Charité

  • Maria Rönnefahrt

    Project coordination of the cooperation in the Clinical Trial Unit of the Clinical Study Center (CSC), BIH, Charité

    Contact information
    Phone:+49 30 450 643 653
  • Luise Roither

    Strategic Co-operations Manager

    Contact information
    Phone:+49 30 450 543 025